|
Mar 3
|
Fresenius Seeks €1.1 Billion for Stake in Dialysis Company
|
|
Feb 28
|
Is It Time To Consider Buying Fresenius SE & Co. KGaA (ETR:FRE)?
|
|
Feb 27
|
Fresenius SE & Co KGaA (FSNUF) Full Year 2024 Earnings Call Highlights: Strong Growth and ...
|
|
Feb 26
|
Germany's Fresenius tops profit estimates on strong drug unit performance
|
|
Oct 10
|
Is Fresenius SE & Co. (FSNUY) Stock Undervalued Right Now?
|
|
Oct 9
|
Fresenius SE & Co KGaA (FSNUF) Q2 2024 Earnings Call Highlights: Strong Revenue Growth and ...
|
|
Oct 9
|
Baxter's North Carolina Facility Manufactures ~60% Of IV Fluids And Peritoneal Dialysis Solutions, Senator Demands Immediate Action To Protect Patient Care Amid Shortage
|
|
Oct 8
|
Here's Why Fresenius (FMS) is a Strong Value Stock
|
|
Oct 8
|
Fresenius looking to boost output after hurricane damage at rival Baxter
|
|
Oct 7
|
While institutions own 30% of Fresenius SE & Co. KGaA (ETR:FRE), individual investors are its largest shareholders with 43% ownership
|
|
Jun 19
|
Why Fresenius (FMS) is a Top Value Stock for the Long-Term
|
|
May 8
|
UPDATE 2-Fresenius raises outlook on strong quarterly results, exits Vamed
|
|
May 2
|
Fresenius Sells Controlling Stake in Vamed Rehab Business to PAI
|
|
Apr 30
|
Institutions own 30% of Fresenius SE & Co. KGaA (ETR:FRE) shares but retail investors control 43% of the company
|
|
Jan 11
|
Is Fresenius SE & Co. KGaA (ETR:FRE) Trading At A 45% Discount?
|
|
Dec 8
|
The past five years for Fresenius SE KGaA (ETR:FRE) investors has not been profitable
|
|
Dec 7
|
Globus Medical (GMED) Down 3.1% Since Last Earnings Report: Can It Rebound?
|